Avac Event
Join us for a conversation about STI and HIV testing in the modern era with dialogue from both health care providers and patient perspectives.
During this webinar attendees will learn about:
Avac Event
The 13th International AIDS Society (IAS) conference on HIV science will take place in Kigali, Rwanda, and virtually, from July 13-17, with pre-conferences on July 13.
This biennial conference presents the latest HIV research and innovations that move science into policy and practice. IAS 2025 will also address the current political and financial issues affecting the HIV response, including the implications for Africa and around the world.
View the conference program. And watch this space for AVAC’s forthcoming conference roadmap and other resources.
Avac Event
The International AIDS Society (IAS) is partnering with the International Society for Vaccines (ISV) to host a virtual mini-symposium on HIV vaccine research and development (R&D). Be sure to take up this unique opportunity to engage with cutting-edge research and contribute to the ongoing dialogue around HIV vaccine development.
Event speakers
Part of ISV’s quarterly Mini Symposia series, this session brings together global leaders in HIV vaccine R&D to share the latest research, challenges and breakthroughs in the field.
Join us in a discussion with:
Avac Event
While the HIV prevention buffet will soon offer a second form of long acting injectable PrEP, ensuring access to all those who can benefit requires innovations in service delivery such as task shifting. In the United States, two Federally Qualified Health Centers (FQHCs) have implemented programming that has expanded clinic capacity, resulting in more individuals being able to choose long acting injectable PrEP. We also heard about innovative efforts to expand PrEP access in South Africa and learned what it takes to integrate task shifting for long-acting PrEP injection programs. We discussed other ways we can collectively innovate to support expanded, sustainable access to all forms of PrEP.
Speakers:
Moderator:
Materials:
Avac Event
On June 11, AVAC hosted a conversation, The Scientific Journey of Lenacapavir: From basic science to clinical development to impact, to explore how US support from NIH for basic science and South Africa’s clinical research infrastructure made possible the development of lenacapavir for PrEP (LEN), a discovery in HIV prevention that went on to be named Science magazine’s 2024 Breakthrough of the Year.
As the field anticipates initial regulatory approval from the US FDA by June 19 and a WHO recommendation in July, Linda-Gail Bekker of the Desmond Tutu Health Foundation, Wes Sundquist of the University of Utah and Mitchell Warren of AVAC underscored how this moment of promise is threatened by sweeping attacks on science, research and the very systems that made the development of LEN possible.
Avac Event
Join HIV cure advocates and the Afrovive Health Foundation executive director to discuss the latest on HIV cure research.
Featuring:
Meeting Details:
12pm EAT. Join via Microsoft Teams.
Avac Event
The Towards an HIV Cure programme of IAS – the International AIDS Society – invites you to a webinar, titled “On the road to IAS 2025: Scientific highlights in HIV cure research”.
This webinar will set the scene for the pre-conference, “Co-infections, viral and host diversity: Impact on HIV cure strategies”, taking place on 13 July at IAS 2025, the 13th IAS Conference on HIV Science. It will highlight key scientific developments presented at CROI 2025 and the Keystone Symposia, “HIV Cure: Antiretroviral-Free Control of HIV Infection”, and explore how these findings are shaping the HIV cure field and informing the conversation leading up to IAS 2025.
Confirmed Speakers
Avac Event
Join AVAC and GBGMC for the next “Fight For Our Lives” Emergency Townhall to learn more about how the recent freeze on US government foreign assistance has impacted the availability of PrEP, including the rollout of injectable cabotegravir for PrEP, and what this means for key populations and LGBTQ+ communities.
This is an ongoing series. Forthcoming times shown are Eastern Time. Find the time in your region here.
Avac Event
With the increased abuse of technology in surveilling and criminalizing healthcare, especially abortion and gender affirming care, more and more people are asking: is my personal health data safe?
People living with HIV and human rights advocates have been demanding answers to this question for years, particularly in relation to the collection, sharing, and storing of HIV genetic data without the consent of people living with HIV.
Kendra Albert, a public interest technology lawyer, discussed the current state of health data privacy, especially as it relates to people living with HIV. Participants learned basic concepts in health data privacy and what actions they can take to improve health data privacy on the state level.
Moderator:
Presenters:
Materials:
Avac Event
The International Workshop On Long Acting Anti-Infectives (LAAI) is a crucial platform for advancing the development, implementation, and scale-up of long-acting and extended-release (LA/ER) anti-infective therapies.
AVAC’s Stacey Hannah will present on, Getting It Right This Time: The Impact of PEPFAR Stop Work Orders on Injectable PrEP and Implications for LEN Rollout.